Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids
- PMID: 698279
- DOI: 10.1016/s0006-3061(00)80286-0
Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids
Abstract
The ionization constants and some divalent cation dissociation constants of nalidixic and oxolinic acids, both specific inhibitors of bacterial DNA replication, have been determined. The carboxylic pKa' values are 6.1 and 6.9 at 25 degrees for nalidixic and oxolinic acids, respectively. These values indicate that intramolecular hydrogen-bonding stabilizes the un-ionized form of these compounds in aqueous solution. Both compounds bind divalent cations; the divalent cation dissociation constants for oxolinic acid are somewhat smaller that those for nalidixic acid. We suggest that both compounds may act by forming a complex in situ with a divalent cation in a metalloprotein involved in DNA replication. The evidence that both drugs inhibit at the same target site is briefly reviewed.
Similar articles
-
Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.Antimicrob Agents Chemother. 1978 Mar;13(3):479-83. doi: 10.1128/AAC.13.3.479. Antimicrob Agents Chemother. 1978. PMID: 400825 Free PMC article.
-
Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.Antimicrob Agents Chemother. 1978 Mar;13(3):533-5. doi: 10.1128/AAC.13.3.533. Antimicrob Agents Chemother. 1978. PMID: 263890 Free PMC article.
-
Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.Proc Natl Acad Sci U S A. 1977 Nov;74(11):4767-71. doi: 10.1073/pnas.74.11.4767. Proc Natl Acad Sci U S A. 1977. PMID: 200930 Free PMC article.
-
Actin-bound nucleotide/divalent cation interactions.Adv Exp Med Biol. 1994;358:35-49. doi: 10.1007/978-1-4615-2578-3_4. Adv Exp Med Biol. 1994. PMID: 7801810 Review.
-
The missing hydrogen ion, part-1: Historical precedents vs. fundamental concepts.Sports Med Health Sci. 2023 Nov 10;5(4):336-343. doi: 10.1016/j.smhs.2023.10.008. eCollection 2023 Dec. Sports Med Health Sci. 2023. PMID: 38314048 Free PMC article. Review.
Cited by
-
Clinically significant drug interactions with antacids: an update.Drugs. 2011 Oct 1;71(14):1839-64. doi: 10.2165/11593990-000000000-00000. Drugs. 2011. PMID: 21942976 Review.
-
Milk and yoghurt do not impair the absorption of ofloxacin.Br J Clin Pharmacol. 1992 Mar;33(3):346-8. doi: 10.1111/j.1365-2125.1992.tb04050.x. Br J Clin Pharmacol. 1992. PMID: 1576061 Free PMC article. Clinical Trial.
-
Iron supplements: a common cause of drug interactions.Br J Clin Pharmacol. 1991 Mar;31(3):251-5. doi: 10.1111/j.1365-2125.1991.tb05525.x. Br J Clin Pharmacol. 1991. PMID: 2054263 Free PMC article. Review.
-
Fluoroquinolones: interaction profile during enteral absorption.Drugs. 1993;45 Suppl 3:65-72. doi: 10.2165/00003495-199300453-00013. Drugs. 1993. PMID: 7689454 Review.
-
Effect of antacid on absorption of the quinolone lomefloxacin.Antimicrob Agents Chemother. 1992 Jun;36(6):1219-24. doi: 10.1128/AAC.36.6.1219. Antimicrob Agents Chemother. 1992. PMID: 1329615 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources